DOJ Launches Task Force on Healthcare Monopolies: Will It Make A Difference?
The U.S. Department of Justice recently launched a task force on healthcare monopolies. Experts have varying opinions on how it will impact the healthcare industry.
The U.S. Department of Justice recently launched a task force on healthcare monopolies. Experts have varying opinions on how it will impact the healthcare industry.
At the HLTH conference last week, MedCity News' editorial team interviewed 11 health leaders from a variety of organizations to get a sense of which areas within healthcare will see consolidation over the next 12 months.
In an era of escalating healthcare costs and a growing preference for natural, holistic approaches to health, The Impact Brands emerges as a collective of diverse brands dedicated to supporting overall wellness through natural means.
Endless digital health solutions have emerged over the last few years. But eventually, they'll have to consolidate — and that's part of the cycle, investors said during a panel discussion on Sunday.
As macroeconomic forces continue to negatively impact the healthcare sector, health tech experts predict that 2023 will be another slow year for the IPO market. However, they think consolidation deals will continue to be a constant, according to a new report.
About 73% of health insurance markets are highly concentrated, and in 46% of markets, one insurer had a share of 50% or more, a new report from the American Medical Association shows. The report comes a few months after President Joe Biden directed federal agencies to ramp up oversight of healthcare consolidation.
Independent physician practices are being gobbled up by hospitals, payers and private equity, and while some see it as a boon for the practices and industry as a whole, others believe it will raise costs and block access to care.
This eBook, in collaboration with Care Logistics, details how hospitals and health systems can facilitate more effective decision-making by operationalizing elevated awareness.
President Joe Biden's new executive order aimed at reducing anti-competitive behavior across industries includes directing federal agencies to revise guidelines for hospital mergers, enable people to comparison shop health plans on the ACA marketplaces and work with states to import drugs from Canada.
Though there has been a slew of failed merger plans in recent months, providers' interest in consolidation has not ebbed. Midwest-based Beaumont Health and Spectrum Health announced they are exploring a merger, as did Rush Health Systems and Ochsner Health, which are located in the South.
M&A activity in the healthcare finance technology is heating up, evidenced by large transactions such as Cedar buying OODA Health and R1 RCM buying VisitPay. Experts agree that this activity won't end anytime soon, and it will have a positive impact on providers and patients.
As a result of rapid consolidation, the 10 biggest health systems controlled 24% of market share based on patient revenue by 2018. The trend is expected to continue through the next decade, with health systems facing growing financial pressures and an increase in demand for new types of care delivery.
Canada has a proud history of achievement in the areas of science and technology, and the field of biomanufacturing and life sciences is no exception.
If the merger is approved, the combined health system would operate 70 hospitals and employ 89,000 people. Intermountain CEO Dr. Marc Harrison would lead the new system, estimated to generate about $15 billion in annual revenue.